Multiple Assemblies exist for SMTL entry 5vzx
Crystal structure of crenezumab Fab; X-RAY DIFFRACTION 2.50 Å

	SMTL ID 5vzx.1 Ligands SULFATE ION; 2-(N-MORPHOLINO)-ETHANESULFONIC ACID; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides Crenezumab Fab heavy chain; Crenezumab Fab light chain Oligo-state hetero-oligomer
	SMTL ID 5vzx.2 Ligands SULFATE ION; 2-(N-MORPHOLINO)-ETHANESULFONIC ACID; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides Crenezumab Fab heavy chain; Crenezumab Fab light chain Oligo-state hetero-oligomer
	SMTL ID 5vzx.3 Ligands SULFATE ION; 2-(N-MORPHOLINO)-ETHANESULFONIC ACID; 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID Polypeptides Crenezumab Fab heavy chain; Crenezumab Fab light chain Oligo-state hetero-oligomer